ANGIOGENEX, INC.

Profile

Company Names

ANGIOGENEX, INC.

Addresses

425 MADISON AVENUE, SUITE 902, NEW YORK, NY 10017

Phone Numbers

212-874-6608

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$285,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-12-17 
$260,000.00 
$260,000.00 
$0.00 
Debt 
1
2009-11-16 
$25,000.00 
$500,000.00 
$475,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
ARONSTEIN 
EXECUTIVE OFFICER, DIRECTOR
ANGIOGENEX, INC.
WILLIAM 
 
GARLAND 
EXECUTIVE OFFICER, DIRECTOR
ANGIOGENEX, INC.
MARTIN 
 
MURRAY 
EXECUTIVE OFFICER, DIRECTOR
ANGIOGENEX, INC.   |  FULCRUM BIOENERGY INC
RICHARD 
 
SALVADOR 
EXECUTIVE OFFICER, DIRECTOR
ANGIOGENEX, INC.
MICHAEL 
 
STRAGE 
DIRECTOR, EXECUTIVE OFFICER
ANGIOGENEX, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-12-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2021-12-17 
2009-12-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2009-11-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
JOHN D. TRENHOLM
1053437
CHOICE INVESTMENTS, INC.
17665
WILLIAM H. WATSON, III
1016938
CHOICE INVESTMENTS, INC.
17665